Innovative Biosurgery
Founded in 2005 and based in the Lyon suburb of Saint-Priest (France), Biom’up develops and commercializes hemostatic products based on patented biopolymers designed to simplify traditional and laparoscopic surgical procedures in numerous specialties such as cardiac, general and orthopedic, and give patients a better quality of life. The Company’s lead product, HEMOBLASTTM Bellows, is marketed in Europe and the United States.
Biotechnologie, Dispositifs Médicaux Implantables, Collagène, Equipements médicaux, Hémostase, Innovative biosurgery, Medical devices, Hemostasis, Collagen, Biotechnology, Pharmacy, Hemoblast, hemostatic, medical devices, and hemostasis
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Groupe Hospitalier Diaconesses Croix Saint-Simon Health, Hospitals and Health Care | Groupe Hospitalier Diaconesses Croix Saint-Simon Health, Hospitals and Health Care | Not capitalistic Not partnership Event 15 Mar 2019 | |